Ingelvac MycoFLEX http://www.flexcombo.com/mycoflex Boerhringer Ingelheim's Mycoflex Swine Vaccine provides protection from Porcine enzootic pneumonia, caused by Mycoplasma Hyopneumoniae in swine herds. THE LEADING MYCO VACCINE IS ALSO THE MOST FLEXIBLE TO USE Ingelvac MycoFLEX® from Boehringer Ingelheim delivers rapid onset of immunity and 26 weeks of protection in a single dose.1 And Ingelvac MycoFLEX offers more flexibility in your treatment. MYCOPLASMA HYOPNEUMONIAE RESPIRATORY DISEASE Porcine enzootic pneumonia, caused by Mycoplasma hyopneumoniae, is the leading cause of respiratory disease in today’s swine production systems. It can affect pigs of all ages, but infection and clinical disease normally occur during the finishing phase. Symptoms include:   Deep, non-productive cough Fever Reduction in feed intake Reduction in Average Daily Gain Susceptibility to other respiratory infections 26 WEEKS OF PROTECTION, IN A SINGLE DOSE1 Ingelvac MycoFLEX is a highly syringeable vaccine for use in pigs 3 weeks of age or older One-dose protection against Mycoplasma hyopneumoniae Duration of immunity of at least 26 weeks Revolutionary ImpranFLEX™ adjuvant provides rapid and long-lasting immunity A PROVEN SAFETY PROFILE ImpranFLEX aqueous-based adjuvant is easy on pigs No tissue reaction compared to oil-based adjuvants Reduces stress on pigs and virtually eliminates injection site lesions TOTAL FLEXIBILITY Single-dose formula requires less time and labor Less stress on pigs Compatible with PQA guidelines Can be mixed with Ingelvac CircoFLEX® for one-dose protection against Mycoplasma hyopneumoniae and PCVAD (circovirus) Can be used as early as three weeks of age, providing immunity throughout the grow-finish period May also be administered later in the nursery, depending on exposure patterns in herd REDUCED CLINICAL SIGNS, LUNG LESIONS AND PNEUMONIA1 Field studies prove Ingelvac MycoFLEX reduces the clinical signs, lung lesions and pneumonia associated with Mycoplasma hyopneumoniae infection.In a blinded clinical trial, pigs vaccinated at three weeks showed significantly lower lung lesion scores compared to the challenge control group.1 References1. Technical Bulletin “Ingelvac MycoFLEX provides at least 26 weeks duration of immunity”. BI S2007-1M-TBR 2/08. Available from Boehringer Ingelheim Technical Services at 800-325-9167.